menotropins has been researched along with Autoimmune-Diseases* in 2 studies
2 other study(ies) available for menotropins and Autoimmune-Diseases
Article | Year |
---|---|
Effective ovarian stimulation in a patient with resistant ovary syndrome and antigonadotrophin antibodies.
We report on a successful ovarian stimulation and pregnancy in a patient with 'resistant ovary syndrome' (ROS) and antigonadotrophin antibodies. ROS is characterized by high endogenous gonadotrophins, low estradiol, normal ovarian antral follicle counts and normal antimuellerian hormone values.. After cyclical hormone treatment, downregulation with GnRH analogue and ICSI procedure followed. Granulosa cells were treated with LH, FSH or hMG and expression of receptors for FSH, LH, oestrogen receptor beta (ERb) and progesterone receptor A (PR-A) was determined. Serum of the patient was analysed for antibodies directed against hMG.. After fertilization of ten metaphase II oocytes and transfer of two blastocysts, a singleton pregnancy was established. Stimulation of granulosa cells with FSH, LH and hMG upregulated ERb and PR-A. Dot blot analysis showed strong reactivity with hMG but not with recFSH.. This patient with normal expression of gonadotrophin receptors showed antibodies directed to hMG but not to recFSH. Topics: Adult; Autoimmune Diseases; Female; Humans; Immunoglobulin G; Immunoglobulin M; Menotropins; Ovulation Induction; Pregnancy; Primary Ovarian Insufficiency | 2015 |
Ovulation induction and early pregnancy loss in a woman susceptible to autoimmune diseases: a possible interrelationship.
We report a 34-year-old woman with sequentially occurring autoimmune diseases that are possibly triggered by numerous ovulation inductions. At the ages of 26-32 years, she experienced 27 uncontrolled ovulation induction cycles using clomiphene citrate (CC) or CC plus human menopausal gonadotropin plus human chorionic gonadotropin. She became pregnant at the ages of 27, 30 and 31 with subsequent pregnancy loss in the 28th, 8th and 10th week of gestation, respectively. Insulin-dependent diabetes mellitus (IDDM) developed at the age of 28. During the second year of ovulation induction, at the age of 27, she developed arthralgia that worsened and became migratory from the age of 31. Thrombocytopenia appeared at the age of 33. The diagnosis of systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) was established at the age of 34. To the best of our knowledge, this is the first case of concurrent IDDM, SLE and APS in a patient associated with ovulation inductions. Excessive levels of estradiol achieved during the ovulation inductions could play a role in the expression of multiple autoimmune diseases in the susceptible woman. Topics: Abortion, Spontaneous; Adult; Antiphospholipid Syndrome; Arthralgia; Autoimmune Diseases; Chorionic Gonadotropin; Clomiphene; Diabetes Mellitus, Type 1; Female; Humans; Lupus Erythematosus, Systemic; Menotropins; Ovulation Induction; Pregnancy | 2000 |